Pathology EMQ template.

Name: Jeremy Webb

Theme: Immune therapies

 

OPTION LIST

 

A	Adalimumab	I	Mycophenolate Mofetil
B	Basiliximab	J	Plasmapharesis
C	Certolizumab	K	Rituximab
D	Corticosteroids	L	Ustekinumab
E	Cyclophosphamide	M	None of the above
F	Etanercept	N
G	Infliximab	O
H	Methotrexate	P

 

 

For each scenario below, choose the most appropriate answer from the list above. Each option may be used once, more than once or not at all.

 

1. Reduces prostaglandin synthesis, inhibits phagocyte migration and function and inhibits lymphocyte function and promotes apoptosis.

 

2. Anti-proliferative agent that has become a widely used alternative to azathioprine following transplantation.

 

3. Fusion protein antagonist of TNFα and TNFβ, which is given as weekly subcutaneous injections.

 

4. Anti-CD25 antibody used for prophylaxis of allograft rejection.

 

 

5. Antibody to p40 subunit of IL-12 and IL-23, used in the treatment of psoriasis.

 

 

 

ANSWERS

1. D

2. I

3. F

4. B

5. L